English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Saturday, October 26, 2024
Press Releases for Monday, October 21, 2024
Acrometa Group to Divest Its Life Sciences Business, Pursue New Business Opportunities in the Region
22:50 HKT/SGT
GMG Provides Business Update on Australian Federal Government Engagement
20:29 HKT/SGT
FishWar Officially Powered by Sei: Elevating the GameFi Experience
20:00 HKT/SGT
Hong Kong International Wine & Spirits Fair opens next month
19:39 HKT/SGT
康哲藥業入選2024年度「中國醫藥上市公司ESG競爭力」系列榜單
19:18 HKT/SGT
康哲药业入选2024年度“中国医药上市公司ESG竞争力”系列榜单
19:15 HKT/SGT
FishWar Officially Powered by Sei: Elevating the GameFi Experience
19:00 HKT/SGT
三菱重工、人事異動を発表
16:00 HKT/SGT
JCBと富士通、中央銀行デジタル通貨を活用した、異なるキャッシュレスサービス間での取引実現に向け、ホワイトペーパーを発行
16:00 HKT/SGT
Majority of Singapore Employees Comfortable Discussing Mental Health at Work, foundit Survey Reveals
16:00 HKT/SGT
GTJAI Wins Multiple Awards at HKQAA Hong Kong Green and Sustainable Finance Awards 2024
15:48 HKT/SGT
國泰君安國際榮獲HKQAA香港綠色和可持續金融大奬 2024多項殊榮
15:44 HKT/SGT
国泰君安国际荣获HKQAA香港绿色和可持续金融大奬 2024多项殊荣
15:40 HKT/SGT
Learn & Get Inspired at the Global STEM Confex
15:00 HKT/SGT
TOYOTA GAZOO Racing closes the gap before the final round
12:27 HKT/SGT
Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment of Primary IgA Nephropathy
12:19 HKT/SGT
云顶新耀宣布中国台湾地区药政部门批准全球首个对因治疗IgA肾病药物耐赋康®的新药上市许可申请
12:08 HKT/SGT
雲頂新耀宣佈中國台灣地區藥政部門批准全球首個對因治療IgA腎病藥物耐賦康®的新藥上市許可申請
11:44 HKT/SGT
Ching Lee Holdings practices CSR to promote sustainability in the construction industry
11:12 HKT/SGT
JCB and GHL Expand Payment Options across Malaysia, Thailand and the Philippines
11:00 HKT/SGT
正利控股推动建筑业可持续发展与企业社会责任实践
10:56 HKT/SGT
正利控股推動建築業可持續發展與企業社會責任實踐
10:01 HKT/SGT
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
10:00 HKT/SGT
ACN Search:
Andy Pitre, EVP of Product, HubSpot, launching Breeze at INBOUND 2024
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575